多发多发髓瘤性骨新药性骨性周髓瘤新药性周围神相关究进性周性周展变研围神经病变研究进展

摘　要：多发性骨多发性骨多发性骨髓瘤（Multioma，oma，ple 性增殖性Myel性增殖性oma，疾病，该MM）是类疾病目浆细胞恶类疾病目MM）是剂等逐渐发性骨髓浆细胞恶性增殖性应用于多瘤患者的疾病，该来新一代类疾病目前无法治性周围神高了骨髓，但是由愈，近年来新一代免疫调节剂、蛋白药物相关酶体抑制酶体抑制剂等逐渐多发性骨发性骨髓成为影响应用于多发性骨髓瘤患者的瘤患者的主要针对总生存期素。本文作一综述成为影响瘤的治疗，明显提性周围神髓瘤患者药物相关高了骨髓作一综述性周围神经病变也素。本文瘤患者的总生存期药物相关，但是由研究进展素。本文性周围神此产生的此产生的药物相关性周围神经病变也素。本文成为影响患者生活质量及治疗依从性的主要因素。本文性周围神主要针对多发性骨髓瘤患者药物相关性周围神经病变的研究进展作一综述。

【分　类】 【医药、卫生】 > 临床医学
【关键词】 多发性骨髓瘤 免疫调节剂 蛋白酶体抑制剂 周围神经病变
【出　处】 《中文科技期刊数刊刊（文数据文文摘卫医库卫（）生文卫医文摘版）药医药药卫生》2018年 第05月 02 402-404页　共3页
【收　录】 中文科技期刊数据库

【参考文献】
[1][1]周剑峰周剑峰，孙汉义成.，孙汉英，张-3版义成.[M]义成..科学13，-3版13，血液病13，诊疗指南---3版[M]13，.20出版社[M]:15.科学出版社.20.209-113，1 0:15Mic hoSha69．le L MShaet attya nce9-1et 69．ya ide [2nce]Arattothle eriIncan,auerderalya rmaShahy d puroh, E Mopu nehemideopuJ Nattauehewurgrdehor hoffman,Micf chelpy-opuerile L Mauermaeurnn, anet al.Incidehemisence会血液8 ??co and dlatin JuniseaseJunpy-hy 家共识 bu业委员urg4] 8 ?Neuerirden ohy (6)f c606hemrkr发性骨oth4] . 中ion会血液era5，58 ?5，5py-of indJ Nuced p,etpheeri[J]phes wMilraloma年 ) ne L,uropathy in eshurg 多发a propy it[Jt[Jionn p;89变诊疗opuith anlat m-ion-balecsedlin?cohor神经病t[J]. urg业委员. 中 (2nceern] Vropof J Nido会 .kine o Pslogic eur507sio性骨髓he ] .rol.20eshatt,Waidool s oNeu Psross wg[Jurgy o Psidirkrmonych] .iatithry 06,201J,Snt L,201]中国8 ?Jun] Veat;89rop神经病e ora 分会多:63髓瘤专s o(6)witith.20she:636-641.eshrop (2d t [3.20 [5]中国 trcer-45rinath业委员10)医师协] T会血液科医师cer分会多s wTZ 发性骨髓瘤专kinrol业委员andath会 . 多发性骨髓J C瘤周围pat L, [5Can trneu神经病变诊疗ingelo(27she4（9idieurmid中国专家共识nt rol (2hal015,20年 ),20ccun pmidkin[J]. 中tur9． -20 paib 14. alCar] V TM华内科A ,e oTZ 杂志，201 tr.20noceat06,.20rett ortsheDe nsi5，54（9,Wa] .）:603-606. [eatitheli4] ] .Milialhe V1,proin eshprokin anssiline:p TM an L,Stas wrkreurP iret,DaialJ Cy B]．Bpatt om radret,etangal. Dv [6fet217ssi217nt elo Ha SP DRCar eypme DR10)nt of neueurcer,alctoropathe en ty in p th14. pabehatientpek ReTZ 9． s w co(27ng Ha] Vlecith m-s wret,etyeloma/ormonul tr Ph18．eureated 24with tce rvelzow-ghald tido DRncemidlicul linproe:prchdvaatturorte,etlin24.tiperns of occutanrre nence,Watheece06, and t24.njihe androle of eleca.2t trophyciapatsiolog18．ic ed monitoring[Jons [Jnt ] .assJ Cmuladv].Bliname Onceln Ne irche mtorece.2006, 24 an(2714.):4507-4514.Dis [5forts ] V201n Nranidishera AP rvenag,Wang d wsa -aglicJ,Spekyeltornatd w. [Par pay mrac TM,eteat al,etrat tr.Safety orfiIenelaeur25(f BswaTZ le retnatdenreaeraIentmedenoma M,ri,asslinnt proforate paiti,Mients wic Canith loof 631w-ghe rade periphe:1-patnagral机制[ neumatipof n turopat cohy nag SG CGon [6eurduringali thloge initial [9 treat al(15ment[Jnci.[J].Sifesa licupport Ca29-re yraCan. [cermur.20in a a r. [ostionnsiic Domlon [Jomide ].B29- tr17,), cliamb.Inal llae m25(10)16( ,3217and-32mulipludy24. by M, [6 ix] Tterhawul rveani SP,Tanji K,De Souh r Jo ne骨髓瘤es sa EA re,et CG）:6 alrch．Borteandof entspir-a przom Lorteyraib pl.Inasshilociandated demyla ib ,6:elip-snatJ]．itythaon muli V,etera．Thlon-18 (4ing neM,europsepathy clieri202ophatinical atoysithyinaand pathologw-dic ,et致相关urofea．Thtures [J]．J InClin N efeurom pheuserteimo佐米和[J]ul ,Caien stDismibrd,,20e m15,( 116(A.D4)：h m11]al.psen rven202rfi-209． [7] Quanuolo M,:49m nCarmidozzi Vate．Th Halonmuluroent2) natlogiplA ,Dom ey SG [9 et,al．Bo7-5tonidorte,6:pat:a zom ixry oma MVib mul016 trd/ 11eatl.Sment licterproduc.山东enttices nocifenconsierimiz5] ve omabehophavih ror M-0．Thandd pe m:49t ad.2in chang a stue met es ,Ca实践, Reegein ATUthe ex[J]pression ne -18ortts of TRPV1,ts mibinc CGrit [J lemuland PGRP, anhasombd s32.014ubstance P ipatavilphn t128rvet an ani of ranhe ratxam M s o DRa.2G, spiithvennal cord,tez anipl Remidlonlogipld sATUeriudygicciatic nerve.[Jhasomb]硼替ne patTor]．BioMed era Real.seawitamerch Inish66.d.2ter626k fllanat66.o Rorsionrala.2014:1- anty eraassCon18．. [. [ [8]R Matieninciph] SDonippaldced Hang rvey.Inciden2]Knd torin S(Mtudterce 165andedp managomaomi量硼替ement of Euradvy[Jerse eng socvenycots Dalin umapatal asoasoients mule inoswit[J]h rdomtrielap-sevaed andoma [1[J]in iph/or re医药.fra de[J]8]Ccto [1,Olr-ancopatry deM,emultiple elaidoorsmyeof re lomnd MV128a receiviin ng 201f, singleb-i a ix po-agysillaenttie carfiace-40 lelzohajamemib [Jose].Clin亚男，s MM,e Pharmacoe 2logf ty:Advaomi.20hery[Jera nences and iplmibAppyellicati7,13-16，5onsopaTorher1-2olo. 2(15.Blf 014( 1 re,6:udy87-.Sut o96. Jo [9uba] S [1/dehaji K.A umaoseeuriagr,Pe mhilippe MJ].ore[J]imoherau,Parameardswaran Haharri,pen3. et al.lom (4 Managemeumbatont 理论与ien T,sonof ,etadvouby,2ersA, e einaskaio 1-1 20e ie mvend.27-5ts haryelassociteg prate [1urod wtezith ixrevazo Molem [Jmib52- plidoidous midapits eriIen M ali201domide机制[,Co/deamethason Mee i ran relapsephanduh md/ IST, R66.refrac571se ipll.PContory mYokultde 0):in iplBru161e muceyelyelSTRultPal瘤的效26252-h bopaTorl O,ett o经病变oma [J].Bralomiritish Joultes ripopoers(11 anppoA.Durnal of eurnce efomal.S骨髓瘤re HaePalmatology,合环磷201yel7,178,571-58udyATU2. 孙中伟[10erss M]硼替佐米和沙利度ndung 胺治疗al.xamCon rady her多发性亚男，骨髓瘤致相关周围神经病变dy [1. [机制[J].诊断学omb理论与实践,201ele6,1ysitez5（6yelle PalSus）:629-ini.低剂erie m631. [11]m nege Molle nesturawskaga M,Grz anask6(1o Nd noma6(1 ,Kostyra M ,et a1．Thera瘤的效py-related periphe0):nalral ne [1uropatapiacyhy in mull. [1tiple mye:a ed lom a umbwitpatienM,ets[J]．Hemaloatol Oncomatl,2014,33 (4) : 113-1acy19.witarif t [1.山东2]Kysiamimidmur[J]a T,Mioodyam: toto T,Yokota(15iatmib N,iplco et [J]al.Periphneueral neurart peeuropathy exacer-a201ted201ect by lenalseridomide in a paalaalotient 31.neuwitrt 性骨髓201h multiple meurultithg--Fedyelomaoto[J].Inherter neuloPal MeMeld.2014;53(15), 1651-1athConoub653. [),113]DalDimla 1;8Torre relultC,Zmenambreviphh mRicse ellrt iagoloM-0 deiveo Rxamopaiag,CaMelcciaris Mwitathllae mni 14,M,et atri量硼替l.Le ineuenalidpenomiudypat.Blk fde long--l. term nA.Dphepat0):eurotoxicitymiz:Cll.P[J]iniyelcal anen d neurandophegeopaysioloapsood10)53.gic prer.ardospectivel. study[J]Eur.Neeaturology,2Sus016pha,87(11),1161-1166.lus [1ed 4] Richardson PG,D03.hicavistuethd S14,S(M,Sih begeoodl,et a52-l.P[20omalid7] omide ti ed alone or incombina10)ne tion with Low-dhicose dexamf methasoe peosne mizeosin rel,Olapsed ofJ].and reomafractory deyelmul.Suh bidotiplemethyelphaoma: a.低剂 raed ndomizmidedphase 2 study[J]1;8.Blstuood.2014,los123( 1y de mf, or 2) : 1826-18h m32. [1mall. 5] ropMeletios A.Dimoy[Jaseafepou瘤的效los,Anton, Rio Paland,etumbBaol no,eb- t ats 6]马l.Safety and efhy ficacy of poyel(4)malidomide plus low-drevathose6，5 dexamethasone in STRATUS(MM-010) MVdon:a 3b phase 3b study in 53.refracen tory multse iplpate myeloma[J].Blhict oood.2016,y o128(4):497-5oma03. ox [16]马亚男，孙中伟.低剂量硼替nos佐米联合环磷23-patyco酰胺治疗多发性骨髓瘤的效果观察[J].山东医药.2016，56(10):52-53. [17] Dimopoulos MA, Maty deos MV, Richardson626in PG506, et al. Risk fy oeate iactors for,and 14,reversibility of, asencoperipheral neuropaot thy aspatsocA siated with bortezoath.A mib-melphalan- predniGA,sone in newly diag Ca626nosed patients with muroultiple myeloma: subanalysis of the phase 3 VISTA study[Jl R]. Eur J ts Haesermatol.2011;86(1): 23-r Tneu31. [18]Cartoni C,Brunetti GA,Fede ferico V,et al. Contrillebord-release oxycodone for the 20 treatment of rt bortezomib-induceduce neuropathic pain in patients with multiple myeloma[J].Suppotezrt Carerie cancer.2012:2api0(10)；262ral1-2ipl626. [19]SusannacuJ].e Koeppen.Treatment of multiple myeloma: thalidomide-,bortezomib-,and lenalidomid4,3e-inducedneu peripheral neuropathy[J].Oncol Res Treat.2014,3tre7 (9):506-513. [20]Ting Bao,Olga Goloubeva,Coes[lleen Pelser,et al.A pilot study of acupunin cture in treating bortezomib- induced peripheral neuropathy in patients with multiple myeloma.Integrative Cancer Therapies[J]. 2014,13(5):396-404.

原文预览